Huichang Bi

12PUBLICATIONS
23CO-AUTHORS
Metabolic medicinePredictive and prognostic markersMetabolomic chemistryCancer diagnosisTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 12, 2025
Development and Validation of a HPLC-MS/MS Method for the Determination of Compound 13b in Rat Plasma and Its Application to a Pharmacokinetic Study.

Guofang Bi, Qingqing Yu, Jiayin Guo

|Jun 18, 2024
Pregnane X receptor activation induces liver enlargement and regeneration and simultaneously promotes the metabolic activity of CYP3A1/2 and CYP2C6/11 in rats.

Guofang Bi, Fengting Liang, Ting Wu

|Jun 20, 2023
μPESI-MS/MS System for Screening and Quantitating Drugs in Plasma Samples.

Simin Zhang, Qian Liu, Xiangyang Qu

|Oct 17, 2022
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization.

Rui Liu, Panpan Liu, Huichang Bi

|May 05, 2022
Paclitaxel-Containing Extract Exerts Anti-Cancer Activity through Oral Administration in A549-Xenografted BALB/C Nude Mice: Synergistic Effect between Paclitaxel and Flavonoids or Lignoids.

Dake Cai, Jing Jin, Huichang Bi

|Aug 13, 2021
YAP-TEAD mediates PPAR α-induced hepatomegaly and liver regeneration in mice.

Shicheng Fan, Yue Gao, Aijuan Qu

Pageof 2

Frequent Collaborators

2 joint publications

Gui-Hua Tang

2 joint publications

Sheng Yin

1 joint publications

Huizhen Zhang

1 joint publications

Le Lv